Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.967
-0.063 (-6.11%)
At close: Nov 20, 2024, 4:00 PM
0.988
+0.021 (2.15%)
Pre-market: Nov 21, 2024, 5:06 AM EST
Adicet Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 5.67, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 486.29% from the current stock price of 0.97.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for Adicet Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 30, 2024 |
| Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +417.01% | Sep 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 19, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.91M
EPS This Year
-1.40
from -3.31
EPS Next Year
-1.36
from -1.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 21.0M | 26.3M | ||
| Avg | n/a | 2.9M | 3.6M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 800.8% | ||
| Avg | - | - | 25.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.41 | -1.05 | -0.91 | ||
| Avg | -1.40 | -1.36 | -1.09 | ||
| Low | -1.37 | -1.53 | -1.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.